Vanadate inhibition of fungal PhyA and bacterial AppA2 histidine acid phosphatases

Abul H Ullah1, Kandan Sethumadhavan, Edward J Mullaney

  • 1Southern Regional Research Center, ARS, USDA, New Orleans, Louisiana 70124, United States. abul.ullah@ars.usda.gov

Insights

Vanadate acts as a molecular switch, inhibiting fungal PhyA phytase and bacterial AppA2 phytase activities at acidic pH. This allows fungal PhyA to function as a vanadate haloperoxidase, showcasing a unique dual-activity mechanism controlled by vanadate.

Area of Science:

  • Biochemistry
  • Enzymology
  • Protein Science

Background:

  • Fungal PhyA protein exhibits acid optimum phosphomonoesterase activity (EC 3.1.3.8).
  • PhyA can also function as a vanadate haloperoxidase (EC 1.11.1.10) when acid phosphatase activity is inhibited by vanadate.

Purpose of the Study:

  • To investigate the inhibitory mechanism of vanadate on fungal PhyA and bacterial AppA2 phytase activities.
  • To elucidate how vanadate modulates the dual catalytic functions of fungal PhyA.

Main Methods:

  • Kinetic experiments were conducted under various acidic pH conditions.
  • Enzyme activity assays were performed in the presence and absence of orthovanadate and metavanadate.
  • Analysis of kinetic parameters (Km and Vmax) was performed for both fungal and bacterial phytases.

Main Results:

  • Orthovanadate potently inhibited fungal phytase at pH 2.5-3.0 (50% inhibition at 0.56 μM).
  • Metavanadate preferentially inhibited bacterial AppA2 phytase (50% inhibition at 8 μM) over fungal phytase (50% inhibition at 40 μM).
  • Vanadate reduced Vmax in bacterial phytase and both Km and Vmax in fungal phytase, suggesting different binding interactions.

Conclusions:

  • Vanadate anions bind to cationic residues in the phytase active site at acidic pH, acting as a molecular switch.
  • This binding inhibits phytase activity while enabling haloperoxidase activity in fungal PhyA.
  • Fungal PhyA possesses a unique active site with distinct centers for phosphomonoesterase and haloperoxidase activities, controlled by vanadate.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...